Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
QuintilesIMS
Dow
McKinsey
Deloitte
Daiichi Sankyo
Moodys
Cipla

Generated: May 23, 2018

DrugPatentWatch Database Preview

METOCLOPRAMIDE INTENSOL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Metoclopramide Intensol patents expire, and what generic alternatives are available?

Metoclopramide Intensol is a drug marketed by Roxane and is included in one NDA.

The generic ingredient in METOCLOPRAMIDE INTENSOL is metoclopramide hydrochloride. There are twelve drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
Summary for METOCLOPRAMIDE INTENSOL
Drug patent expirations by year for METOCLOPRAMIDE INTENSOL
Medical Subject Heading (MeSH) Categories for METOCLOPRAMIDE INTENSOL
Synonyms for METOCLOPRAMIDE INTENSOL
(4-amino-5-chloro-2-methoxyphenyl)-N-[2-(diethylamino)ethyl]carboxamide, chlor ide
2542AH
364-62-5 (Parent)
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide hydrochloride
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide monohydrochloride
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamidehydrochloride
4-Amino-5-Chloro-N-(2-(Diethylamino)Ethyl)-N-Anisamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide hydrochloride
4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide hydrochloride
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-benzamide hydrochloride
4-AMINO-5-CHLORO-N-[2-(DIETHYLAMINO)ETHYL]-2-METHOXYBENZAMIDE MONOHYDROCHLORIDE
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide;hydrochloride
4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-o-anisamide hydrochloride
49625-23-2
7232-21-5
7B1QZY5SWZ
AB1009373
AC1L2MT3
AC1Q3LU2
AHR-3070-C
AK122291
AKOS015889947
AN-16617
AN-40630
API0003351
API0006827
AX8140039
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-, monohydrochloride
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-, monohydrochloride (9CI)
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-, monohydrochloride, monohydrate
Benzamide, 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-, hydrochloride (1:1)
BG0253
C14H22ClN3O2.ClH
C14H22ClN3O2.HCl
CCG-212697
CCRIS 7142
Cerucal
CHEMBL1256771
CPD000058471
CTK8G1096
EINECS 230-634-5
EU-0100762
FT-0657870
FT-0672375
H780
HMS1568J19
HMS1920N15
HS-0006
I01-4517
J10269
KB-240082
KB-304048
KS-000018AM
LP00762
LS-175536
LS-20040
M 0763
Maxolon
MCULE-8548227068
METOCLOPRAMIDE HCL
Metoclopramide hydrochloride
Metoclopramide Hydrochloride (anhydrous)
Metoclopramide hydrochloride [USAN:JAN]
Metoclopramide hydrochloride anhydrous
Metoclopramide hydrochloride, solid
Metoclopramide monohydrochloride
Metoclopramide monohydrochloride monohydrate
Metozolv
Metozolv ODT
MFCD00058011
MFCD00150634
MLS000069667
MLS001074186
MLS002222202
MolPort-003-666-233
NC00519
NCGC00094102-01
NCGC00094102-02
NCGC00094102-03
NCGC00094102-04
NCGC00094102-05
NCGC00261447-01
NSC 354467
NSC-354467
NSC-757117
NSC354467
NSC757117
o-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-, monohydrochloride
o-Anisamide, monohydrochloride
Opera_ID_1671
OR068557
Paspertin
Pharmakon1600-01500410
Prestwick_332
Primperan (tablet)
Reglan ODT
Rimetin
S4289
SAM002554911
SBB058161
SCHEMBL205200
SMR000058471
SPECTRUM1500410
SR-01000000165
SR-01000000165-2
ST24028881
ST51015042
Tox21_500762
UNII-7B1QZY5SWZ
VU0239518-5
WLN: 2N2&2MVR DZ CG FO1 &GH

US Patents and Regulatory Information for METOCLOPRAMIDE INTENSOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane METOCLOPRAMIDE INTENSOL metoclopramide hydrochloride CONCENTRATE;ORAL 072995-001 Jan 30, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
Argus Health
Chinese Patent Office
Express Scripts
Mallinckrodt
Covington
Accenture
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.